1. Home
  2. BLBD vs CRVS Comparison

BLBD vs CRVS Comparison

Compare BLBD & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$54.82

Market Cap

1.7B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$15.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
CRVS
Founded
1927
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2013
2016

Fundamental Metrics

Financial Performance
Metric
BLBD
CRVS
Price
$54.82
$15.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$67.20
$28.00
AVG Volume (30 Days)
470.0K
1.1M
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
22.78
N/A
EPS
0.94
N/A
Revenue
$1,480,099,000.00
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$6.37
N/A
P/E Ratio
$60.12
N/A
Revenue Growth
9.87
N/A
52 Week Low
$30.15
$2.54
52 Week High
$62.90
$26.95

Technical Indicators

Market Signals
Indicator
BLBD
CRVS
Relative Strength Index (RSI) 44.34 41.19
Support Level $54.23 $6.65
Resistance Level $58.57 $18.73
Average True Range (ATR) 2.52 1.02
MACD -0.81 -0.48
Stochastic Oscillator 8.18 11.94

Price Performance

Historical Comparison
BLBD
CRVS

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: